List view / Grid view
2 April 2019 | By Sartorius
Sartorius' Cubis® II balance series offers customisable modularity to ensure compliance with FDA directive 21 CFR Part II and EU Annex 11. This whitepaper outlines details of the technical solutions that will enable companies to achieve full compliance.
19 March 2019 | By Sartorius
Fully customisable enabling thousands of configurations optimised for the user’s workflow and easy, seamless integration with existing lab software and LIMS...
13 January 2016 | By Sartorius
The BIOSTAT® Rocking Motion (RM) bioreactor system ensures optimal process control and cell growth for all single-use cell culture applications.
12 November 2015 | By Sartorius
Sartorius Stedim Biotech (SSB) BioOutsource today announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with an excellent opportunity to discuss the optimum assay design for rapid and accurate biosimilar characterisation…
1 September 2015 | By Sartorius
Sartorius Stedim Biotech, a leading international supplier for the biopharmaceutical industries and GE Healthcare’s Life Sciences business, a provider of start-to-finish enterprise solutions, technologies and services for biopharmaceutical manufacturing, today announced they have entered into a worldwide OEM supply agreement for Sartorius Stedim Biotech’s innovative membrane adsorber purification technology, Sartobind™.
2 July 2015 | By Sartorius
Sartorius Stedim Biotech (SSB), a leading international supplier for the pharma and biotech industries, acquired Cellca GmbH based in Laupheim, Germany. Founded in 2005, the company with around 30 employees generated sales revenue of approximately 6 million euros in 2014.
27 April 2015 | By Sartorius
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, today acquired the Scottish company BioOutsource Ltd.
2 March 2015 | By Sartorius
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, closed fiscal 2014 with significant gains in sales revenue and earnings.
28 January 2015 | By Sartorius
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies,…
21 October 2014 | By Sartorius
Sartorius, a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first nine months of 2014 with substantial gains.
Follow: